AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Levothyroxine Sodium in Nigeria
5 products registered with NAFDAC — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Euthyrox 100 mcg Tablet** Tablet | A4-0147 | Merck Pharmaceutical and Life Sciences Limited | active | 24 Sept 2029 |
| Euthyrox 25 mcg Tablet** Tablet | A4-0161 | Merck Pharmaceutical and Life Sciences Limited | active | 24 Sept 2029 |
| Euthyrox 75 mcg Tablet** Tablet | A4-101015 | Merck Pharmaceutical and Life Sciences Limited | active | 24 Sept 2029 |
| Levothyroxine 50 Microgram Tablets Tablet | A4-100420 | World Wide Commercial Ventures Ltd | active | 5 Jul 2028 |
| Euthyrox 50 mcg Tablet** Tablet | A4-0160 | Merck Pharmaceutical and Life Sciences Limited | active | 24 Sept 2025 |
Levothyroxine Sodium — NAFDAC Registration Details
NAFDAC (Nigeria) has 5 registered products containing Levothyroxine Sodium, of which 5 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Levothyroxine Sodium registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.